We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other ...

But Moderna shares later surged after Oracle Chairman Larry Ellison called out the speed with which ... Moderna stock surged more than 8% after Oracle's Ellison said mRNA-based cancer vaccines could ...

It was an illuminating moment, not just an amusing line. Every new administration has factions that end up hating one another despite being on the same official team. But the second Trump White House ...

In a groundbreaking announcement, former President Donald Trump has unveiled an ambitious $500 billion plan aimed at pioneering a cancer vaccine that could change the landscape of treatment for ...

The latest guidance reduction was the second time in the last six months that the firm has revised its forecast in a negative ...

One day after being sworn in as the 47th president of the United States, Donald Trump revealed the creation of Stargate, a ...

A scene from the first week of the second Trump administration: After the president held a White House event announcing a ...

“Successful self-replication under no human assistance is the essential step for AI to outsmart [humans], and is an early ...

From left: Masayoshi Son, chairman and CEO of SoftBank; Larry Ellison, executive chairman of Oracle; and Sam Altman, CEO of OpenAI listen to President Trump speak at the White House on Jan. 21 ...

Evercore ISI lowered the firm’s price target on Moderna (MRNA) to $50 from $60 and keeps an In Line rating on the shares. The firm is updating ...

Emily Bary is a MarketWatch news editor based in New York. Victor Reklaitis Victor Reklaitis is a Washington Correspondent for MarketWatch. During his time at MarketWatch, he also has served in ...